134 related articles for article (PubMed ID: 33507366)
1. The inpatient burden of pyoderma gangrenosum and associated comorbidities in children in the United States.
Narla S; Silverberg JI
Arch Dermatol Res; 2022 Aug; 314(6):613-617. PubMed ID: 33507366
[TBL] [Abstract][Full Text] [Related]
2. The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States.
Narla S; Silverberg JI
Arch Dermatol Res; 2021 May; 313(4):245-253. PubMed ID: 32620994
[TBL] [Abstract][Full Text] [Related]
3. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
4. The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.
Kaffenberger BH; Hinton A; Krishna SG
J Am Acad Dermatol; 2018 Oct; 79(4):659-663.e2. PubMed ID: 29438762
[TBL] [Abstract][Full Text] [Related]
5. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ; Butler DC; Nelson CA; Noe MH; Tsiaras WG; Lockwood SJ; James WD; Micheletti RG; Rosenbach M; Mostaghimi A
JAMA Dermatol; 2018 Apr; 154(4):409-413. PubMed ID: 29450453
[TBL] [Abstract][Full Text] [Related]
6. Pediatric pyoderma gangrenosum: is it just big wounds on little adults?
Soleimani T; Sasor SE; Spera L; Eppley BE; Socas J; Chu MW; Tholpady SS
J Surg Res; 2016 Nov; 206(1):113-117. PubMed ID: 27916349
[TBL] [Abstract][Full Text] [Related]
7. Costs of Care for Hospitalization for Pemphigus in the United States.
Hsu D; Brieva J; Silverberg JI
JAMA Dermatol; 2016 Jun; 152(6):645-54. PubMed ID: 26865293
[TBL] [Abstract][Full Text] [Related]
8. Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.
Kridin K; Solomon A; Britva RL; Bitan DT; Cohen AD
Immunol Res; 2021 Jun; 69(3):249-254. PubMed ID: 33890227
[TBL] [Abstract][Full Text] [Related]
9. Inpatient burden of juvenile dermatomyositis among children in the United States.
Kwa MC; Silverberg JI; Ardalan K
Pediatr Rheumatol Online J; 2018 Nov; 16(1):70. PubMed ID: 30424778
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases.
Sasor SE; Soleimani T; Chu MW; Cook JA; Nicksic PJ; Tholpady SS
J Wound Care; 2018 Jan; 27(Sup1):S4-S8. PubMed ID: 29334018
[TBL] [Abstract][Full Text] [Related]
11. Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012.
Jockenhöfer F; Klode J; Kröger K; Roesch A; Al Ghazal P; Dissemond J
Int Wound J; 2016 Oct; 13(5):951-6. PubMed ID: 26250591
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
Ren Z; Hsu DY; Brieva J; Silverberg NB; Langan SM; Silverberg JI
Br J Dermatol; 2017 Jan; 176(1):87-99. PubMed ID: 27343837
[TBL] [Abstract][Full Text] [Related]
13. Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014.
Ungprasert P; Koster MJ; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Semin Arthritis Rheum; 2020 Feb; 50(1):66-70. PubMed ID: 31362895
[TBL] [Abstract][Full Text] [Related]
14. Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis.
Xu A; Balgobind A; Strunk A; Garg A; Alloo A
J Am Acad Dermatol; 2020 Aug; 83(2):425-429. PubMed ID: 31400451
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic work-up and treatment in patients with pyoderma gangrenosum: retrospective analysis of US insurance claims-based data.
Shaigany S; Wong PW; Caplan A; Kim RH; Femia A
Arch Dermatol Res; 2023 Jan; 315(1):95-99. PubMed ID: 34714405
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities, mortality and survival in patients with pyoderma gangrenosum: a Danish nationwide registry-nested case-control study.
Ben Abdallah H; Bech R; Fogh K; Olesen AB; Vestergaard C
Br J Dermatol; 2021 Dec; 185(6):1169-1175. PubMed ID: 33969479
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Hospitalization, Length of Stay, and Costs of Care Among Adult and Pediatric Inpatients With Atopic Dermatitis in the United States.
Narla S; Hsu DY; Thyssen JP; Silverberg JI
Dermatitis; 2018; 29(1):22-31. PubMed ID: 29059095
[TBL] [Abstract][Full Text] [Related]
19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Eczema Herpeticum in Hospitalized U.S. Children: Analysis of a Nationwide Cohort.
Hsu DY; Shinkai K; Silverberg JI
J Invest Dermatol; 2018 Feb; 138(2):265-272. PubMed ID: 28927889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
